In Silico to In Vivo: Mutation-Specific Modeling of Arrhythmia Risk⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.  by Mandapati, Ravi & Shivkumar, Kalyanam
Journal of the American College of Cardiology Vol. 60, No. 21, 2012
© 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.060EDITORIAL COMMENT
In Silico to In Vivo:
Mutation-Specific
Modeling of Arrhythmia Risk*
Ravi Mandapati, MD,†§
Kalyanam Shivkumar, MD, PHD†‡
Los Angeles and Loma Linda, California
The assessment of risk of sudden death (SCD) in patients
with long QT syndrome (LQTS), especially those with
mild-to-moderate corrected QT interval (QTc) prolonga-
tion, is the most challenging aspect of caring for such
patients. The incidence of SCD in patients with a normal
QTc interval during the first 40 years of life is about 4%
(1–3), underscoring the need for risk stratification tech-
niques to identify patients at high risk. Current risk assess-
ment in LQTS integrates clinical and genetic features
known to be associated with SCD. The unmet need in the
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clinical setting is the ability to more accurately assess risk.
This could lead to more appropriate use of therapies,
potentially saving lives and avoiding unnecessary treatment.
Features associated with high risk in LQTS include
history of aborted cardiac arrest, history of syncope, marked
QT prolongation, and combinations of age, sex, and LQTS
genetic subtype. Boys are at higher risk than girls, but
during adolescence, the sex–risk relationship changes, and
women have a higher risk than men. Women with LQTS
type LQT2 have an especially high risk, which is even more
pronounced during the postpartum period. Syncope is less
common in patients with LQT3, who not infrequently
present with SCD as their first symptomatic episode (3).
There is a reported 4-fold increase in risk of aborted
cardiac arrest or SCD among patients with a QTc interval
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paper to disclose.500 ms (3,4). However, QTc intervals can vary temporally
and among individuals with the same mutation. The risk
associated with QTc prolongation is more pronounced
among women than men. In women, risk increased with
QTc intervals 500 ms as compared with men, where risk
increased with QTc intervals 550 ms. Mutation charac-
teristics have recently been shown to determine cardiac risk
in patients with confirmed genotypes for LQTS but normal
range QTc intervals (5). This suggests a strong genetic
component to cardiac risk that is not currently understood.
Costa et al. (5) recently reported that in patients with
LQT1, with mutations localized to the membrane-spanning
domains and the cytoplasmic loops of the KCNQ1 protein,
have a greater QTc prolongation during exercise, thereby
increasing risk of cardiac events even during mild exercise.
These findings suggest that a genotype-specific approach,
incorporating clinical and mutation location/functional
data, might further improve the risk assessment and man-
agement of patients with the most common genetic subtype
of LQTS.
Heterogeneity of repolarization is increasingly thought to
be a significant determinant of risk of SCD in LQTS.
Markers of heterogeneity of repolarization identified are
microvolt T-wave alternans, increased T-wave peak to
T-wave end interval, and more recently, dispersion of
mechanical contraction time (6,7). It is yet to be determined
how such markers can be incorporated into models of risk
prediction in LQTS.
In a study published in this issue of the Journal, Hoefen
et al. (8) have demonstrated that computational models can
help estimate risk in patients with LQTS. They developed
an elegant “in silico” 1-dimensional electrocardiographic
(ECG) computer model into which cellular electrophysiol-
ogy functions from wild type and LQT1 mutants was
introduced. The study consisted of a single population of
older LQTS patients and did not include high-risk patients
who died at a young age. The transmural repolarization
(TRP) for each mutation was evaluated in the computer
model and related to adverse cardiac events among patients
with these mutations. They reported that a TRP increase of
10 ms was associated with a 35% increment of adverse
cardiac events. More significantly, they showed that among
patients with mild-to-moderate QTc duration (500 ms),
the risk associated with TRP was maintained, whereas the
patient’s individual QTc interval was not associated with a
significant risk increase after adjustment for TRP. They also
demonstrated that simulated TRP could identify high-risk
mutations.
In this study, it is unclear whether the model-computed
TRP and the measured QTc data are independent predic-
tors; in addition, the relationship between the transmural
ECG and the body surface ECGs needs to be better
defined. Computer modeling using higher-dimensional tis-
sue structure is necessary to study arrhythmia mechanisms
in detail, and therefore, the 1-dimensional model used in
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illustrates the role of computational modeling in risk assess-
ment in patients with mild-to-moderate QTc prolongation
where the greatest challenge lies in risk prediction.
Modeling of electrophysiological parameters started 50
years ago with the Hodgkin-Huxley model of a giant squid
axon (9). Since that time, the models have undergone
extensive modifications and have reached a high degree of
physiological detail, and so can be used to predict conse-
quences of complex changes in channel function to the
overall heart rhythm. Although computational models allow
experimentation with complex biological systems, ulti-
mately, they are only as good as the biological/experimental
data that strengthen them and bring them closer to reality.
Data from voltage clamp experiments are the foundation
for developing a computational model. However, it is well
recognized that there is variability in the same species across
different levels of organization, such as differential expres-
sion of ion channels, in the action potential, and at the
organ level in the range of heart rate, ECG measurements,
and heart rate and response to medications (10–12). In
addition, different combinations of electrophysiological pa-
rameters can generate voltage traces that look virtually
indistinguishable (13). Most models simplify the input data
(which is necessary for computing), and thereby discrepan-
cies can be great when such modeling experiments are
performed to generate predictions. Models that include
multiple experimental results would be expected to generate
more robust predictions (14). The ability of the computa-
tional model to truly allow robust, accurate, and reproduc-
ible throughput testing of ion channel behavior in the
clinical situation is therefore unclear. A variable such as the
activation of the autonomic nervous system can profoundly
alter cellular- and organ-level behavior of electrical propa-
gation and thus impact arrhythmogenesis (15).
We live in a world where mathematical modeling already
makes a great impact on our daily lives. For instance,
weather prediction, a necessity of life, is surprisingly accu-
rate and is a testament to mathematical modeling (16). It is
also an example of a situation where models have been
improved by constant feedback from real-life data, thereby
improving predictions. The fact that sometimes such pre-
dictions fall short (despite years of improvement in that
field) highlights the need for learning about new variables
that need to be discovered in nature. This type of a
progression toward meaningful modeling is bound to hap-
pen in biology as clinical and scientific data are used to
improve models, and modeling in turn prompts new re-
search strategies. Creating a tool for the clinician is a clear
goal of such efforts. The present paper is a very useful step
in this direction.The results of the study by Hoefen et al. (8) are probably
the first report of computer modeling to validate risk
demonstrated in a real patient population. Using a relatively
simple model to validate clinical data illustrates the potential
of computer modeling to predict risk in rare conditions
where prospective trials are difficult to conduct or may never
be done.
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